Effects of atorvastatin and ticagrelor combination therapy on renal function and the levels of suppression of tumorigenicity 2 and interleukin-33 in patients with ST-segment elevation myocardial infarction

OBJECTIVE: We evaluated the effects of atorvastatin and ticagrelor combination therapy on renal function and the levels of suppression of tumorigenicity 2 (ST2) and interleukin 33 (IL-33) in patients with ST-segment elevation myocardial infarction (STEMI). METHODS: Eighty-four STEMI patients who und...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Li, Hu, Miao, Chen, Yuan, Wang, Yijun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Retrospective Clinical Research Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7720335/
https://www.ncbi.nlm.nih.gov/pubmed/33275460
http://dx.doi.org/10.1177/0300060520959502

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7720335/
https://www.ncbi.nlm.nih.gov/pubmed/33275460
http://dx.doi.org/10.1177/0300060520959502

Ejemplares similares